Drawing up more units than prescribed can increase the risk of nausea, vomiting, or other gastrointestinal symptoms, while drawing fewer units than intended may reduce the treatments effectiveness for the intended condition, whether that is blood sugar management or weight management
One is a natural metabolic modulator, while the other alters hormonal responses to food and appetite
Prematurely increasing your dose during a plateau rarely accelerates loss and increases side effect risk
Meanwhile, figures from 2023 show that slightly more than half (57%) of the GLP-1 diabetes drugs in the market are Semaglutide
These differences are strictly within the regulatory standards of each respective country (FDA in the U.S., COFEPRIS in Mexico, and Health Canada in Canada)
Plans could see real savings, Fendrick said, if they covered GLP-1s for initial weight loss then moved people to cheaper options such as more affordable drugs or behavioral health programs to maintain it